Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells

The therapeutic potential of RNA interference (RNAi) has been limited by inefficient delivery of short interfering RNA (siRNA). Tumor-specific recognition can be effectively achieved by antibodies directed against highly expressed cancer cell surface receptors. We investigated the utility of linking...

Descripción completa

Detalles Bibliográficos
Autores principales: Palanca-Wessels, Maria C., Booth, Garrett C., Convertine, Anthony J., Lundy, Brittany B., Berguig, Geoffrey Y., Press, Michael F., Stayton, Patrick S., Press, Oliver W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891060/
https://www.ncbi.nlm.nih.gov/pubmed/26840082
http://dx.doi.org/10.18632/oncotarget.7076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891060/
https://www.ncbi.nlm.nih.gov/pubmed/26840082
http://dx.doi.org/10.18632/oncotarget.7076

Ejemplares similares